FDA Inspection 1252470 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 2077732

The FDA completed an inspection of Biomat USA, Inc. on Feb 27, 2025 in Van Nuys, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 27, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Van Nuys, CA (United States)